Screener
Denali Therapeutics Inc. DNLI Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
FAQ
- What is Denali Therapeutics Inc.'s total assets?
- Denali Therapeutics Inc. (DNLI) reported total assets of $1.16B in Q2 2026.
- How has Denali Therapeutics Inc.'s total assets changed year-over-year?
- Denali Therapeutics Inc.'s total assets decreased by 0.7% year-over-year, from $1.17B to $1.16B.
- What is the long-term trend for Denali Therapeutics Inc.'s total assets?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s total assets has grown at a -6.5% compound annual growth rate (CAGR), from $1.6B to $1.14B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Denali Therapeutics Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude